Gregory B. Lawless
Corporate Officer/Principal at Collins Mabry & Co. LLC
Profile
Gregory B.
Lawless has been Managing Partner of Collins Mabry & Co. since 1998.
Previously, he was President and Chief Executive Officer of Cygnus, Inc. from 1992 to 1998 and President and Chief Operating Officer of Chiron Corporation from 1989 to 1992.
Dr. Lawless received a BS degree in Pharmacy from Fordham University, an MS degree in Analytical Chemistry from St. John's University and a PhD in Physical Organic Chemistry from Temple University.
Gregory B. Lawless active positions
| Companies | Position | Start |
|---|---|---|
| Collins Mabry & Co. LLC | Corporate Officer/Principal | 1997-12-31 |
Former positions of Gregory B. Lawless
| Companies | Position | End |
|---|---|---|
Vyteris, Inc.
 Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Director/Board Member | 2008-02-05 |
| ORASURE TECHNOLOGIES, INC. | Director/Board Member | 2005-05-15 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
| Collins Mabry & Co. LLC |
- Stock Market
- Insiders
- Gregory B. Lawless
